{
    "2020-11-20": [
        [
            {
                "time": "2020-11-18",
                "original_text": "U.S. sees spike in daily COVID-19 cases, hospitalizations surge",
                "features": {
                    "keywords": [
                        "spike",
                        "COVID-19",
                        "hospitalizations",
                        "surge"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "7 Hot Stocks to Buy Before 2021 Ushers in Change",
                "features": {
                    "keywords": [
                        "Hot Stocks",
                        "Buy",
                        "2021"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "Moderna, Pfizer having similar efficacies is ‘quite encouraging’: Doctor on vaccine progress",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Pfizer",
                        "efficacies",
                        "encouraging",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "WHO advises against using Remdesivir to treat COVID-19",
                "features": {
                    "keywords": [
                        "WHO",
                        "Remdesivir",
                        "treat",
                        "COVID-19"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-13",
                "original_text": "Johnson & Johnson ordered to pay $120 million damages in New York baby powder case",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "pay",
                        "damages",
                        "baby powder"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-15",
                "original_text": "Is Johnson & Johnson (JNJ) a Suitable Pick for Value Investors?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Suitable Pick",
                        "Value Investors"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "PFE",
                        "Vaccine",
                        "FDA Updates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "emergency-use",
                        "authorization",
                        "vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-21",
                "original_text": "Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Vaccine Maker",
                        "Blow Past",
                        "Pfizer",
                        "Moderna"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "Coronavirus update: Pfizer/BioNTech file for emergency vaccine use as WHO hits Gilead's remdesivir",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Pfizer/BioNTech",
                        "emergency",
                        "vaccine",
                        "WHO",
                        "Gilead",
                        "remdesivir"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}